Sex‐specific biomarkers in Alzheimer's disease progression: Framingham Heart Study

BACKGROUND: Sex differences in Alzheimer's disease (AD) are not well understood. METHODS: We performed sex‐specific analyses of AD and annualized cognitive decline with clinical and blood biomarker data in participants 60+ years old in the community‐based longitudinal Framingham Heart Study Off...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chunyu, Li, Yi, Nwosu, Adaora, Ang, Ting Fang Alvin, Liu, Yulin, Devine, Sherral, Au, Rhoda, Doraiswamy, P. Murali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Diagnostic and Prognostic Assessment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633867/
https://www.ncbi.nlm.nih.gov/pubmed/36348973
http://dx.doi.org/10.1002/dad2.12369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633867/
https://www.ncbi.nlm.nih.gov/pubmed/36348973
http://dx.doi.org/10.1002/dad2.12369

Ejemplares similares